HOMELINK2: reducing posthospitalization mortality among people living with HIV through structured home care and nutritional supplementation

Active Project Grant Awarded Last action

Award ID
R01MH138270
Recipient
Awarding agency
Obligated
$2,258,098

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 42% complete
Place of performance
Baltimore, MD 21205, USA

Award details come from USAspending.gov.

Description

Abstract
HIV remains the leading cause of death among adults in south africa despite the availability of antiretroviral therapy (art) due to failure to initiate art and failure to remain on art. Among people living with HIV (plwh) who are hospitalized, 17-26% DIE within 6 months of hospital discharge potentially contributing to more than half of all HIV-associated mortality in south africa. There are heterogenous reasons for mortality that include missed diagnoses, psychosocial barriers to completing treatment plans, and structural barriers that include food insecurity. To respond to the complexity of underlying causes of mortality we developed and piloted a disease neutral intervention to reduce posthospitalization mortality: homelink. This intervention consisted of structured posthospitalization home care visits with psychosocial counselling and nutritional supplementation and reduced posthospitalization mortality by 60%. These results raise important questions regarding reproducibility and scale-up of this intervention. In order to inform policy, the most feasible and cost- effective elements need to be identified. Here we are proposing a fully powered study of a refined HOMELINK2 intervention to compare usual care to structured home visits or home visits plus nutritional supplementation. In addition, we will identify underlying mechanisms of the intervention effectiveness including the impact on timeliness of acute care, medical diagnoses, adherence to art (through viral load testing), and psychosocial metrics. We will further assess implementation outcomes to guide future refinement of intervention delivery. Finally, we will use findings from the randomized trial to complete costing and cost-effectiveness analyses to inform policy makers regarding cost of HOMELINK2 and cost-effectiveness of home visits alone or home visits plus nutritional support to inform potential scale-up and long-term sustainability. This project has the potential to generate considerable new knowledge on interventions that could dramatically reduce HIV-associated mortality in south africa and other low- and middle-income settings. This proposed study is very likely to generate actionable knowledge to improve outcomes for plwh and contribute to overall goals of HIV epidemic control.

Transactions

Action Obligated Date
Amendment $284,270
Amendment $407,114
Amendment $266,490
Amendment $0
Amendment $650,112
Original award $650,112

Subawards

Subrecipient Amount Awarded
Wits Health Consortium (Pty) LTD HomeLink2: Reducing posthospitalization mortality among people living with HIV through structured home care and nutritional supplementation $407,114
Seoul National University HomeLink2: Reducing post-hospitalization mortality among people living with HIV through structured home care and nutritional supplementation. $43,200
Wits Health Consortium (Pty) LTD HomeLink2: Reducing posthospitalization mortality among people living with HIV through structured home care and nutritional supplementation $335,769

Quick answers

Who received award R01MH138270?

R01MH138270 was awarded to The Johns Hopkins University by National Institute of Mental Health (National Institutes of Health) on September 4, 2024.

How much is award R01MH138270 worth?

$2,258,098 has been obligated on R01MH138270.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award